Pyxis Oncology to Present Phase 1 MICVO Monotherapy Data
Pyxis Oncology said Phase 1 monotherapy data for micvotabart pelidotin will be featured at EORTC-NCI-AACR.
Pyxis Oncology said Phase 1 monotherapy data for micvotabart pelidotin will be featured at EORTC-NCI-AACR.